Xuehui Fan

23 You Zheng Street
Harbin, 150001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia/reperfusion injury.

Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia/reperfusion injury.

Journal: Scientific reports

Published: March 09, 2024

MyD88 Inhibition Attenuates Cerebral Ischemia-reperfusion Injury by Regulating the Inflammatory Response and Reducing Blood-brain Barrier Damage.

MyD88 Inhibition Attenuates Cerebral Ischemia-reperfusion Injury by Regulating the Inflammatory Response and Reducing Blood-brain Barrier Damage.

Journal: Neuroscience

Published: December 30, 2023

NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation.

NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation.

Journal: Scientific reports

Published: September 26, 2023

Comprehensive analysis of cuproptosis-related genes in immune infiltration in ischemic stroke.

Comprehensive analysis of cuproptosis-related genes in immune infiltration in ischemic stroke.

Journal: Frontiers in neurology

Published: October 22, 2022

Inhibiting Sphingosine 1-Phosphate Receptor Subtype 3 Attenuates Brain Damage During Ischemia-Reperfusion Injury by Regulating nNOS/NO and Oxidative Stress.

Inhibiting Sphingosine 1-Phosphate Receptor Subtype 3 Attenuates Brain Damage During Ischemia-Reperfusion Injury by Regulating nNOS/NO and Oxidative Stress.

Journal: Frontiers in neuroscience

Published: December 18, 2021

S1PR3, as a Core Protein Related to Ischemic Stroke, is Involved in the Regulation of Blood-Brain Barrier Damage.

S1PR3, as a Core Protein Related to Ischemic Stroke, is Involved in the Regulation of Blood-Brain Barrier Damage.

Journal: Frontiers in pharmacology

Published: December 14, 2021

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis.

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis.

Journal: Frontiers in immunology

Published: August 05, 2021

Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis.

Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis.

Journal: Pharmacological research

Published: November 18, 2020

Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage.

Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage.

Journal: Neuropsychiatric disease and treatment

Published: September 21, 2020

Integrated analysis of RNA-binding proteins in human colorectal cancer.

Integrated analysis of RNA-binding proteins in human colorectal cancer.

Journal: World journal of surgical oncology

Published: June 06, 2020

Recent advances of the function of sphingosine 1-phosphate (S1P) receptor S1P3.

Recent advances of the function of sphingosine 1-phosphate (S1P) receptor S1P3.

Journal: Journal of cellular physiology

Published: February 21, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026